Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 14, Number 7—July 2008

Letter

Klebsiella pneumoniae Carbapenemase–2, Buenos Aires, Argentina

Fernando G. Pasteran*Comments to Author , Luis Otaegui*, Leonor Guerriero*, Gabriel Radice†, Ricardo Maggiora†, Melina Rapoport*, Diego Faccone*, Ana Di Martino†, and Marcelo Galas*
Author affiliations: *Instituto Nacional de Enfermedades Infecciosas–ANLIS “Dr. Carlos G. Malbran,” Ciudad Autónoma de Buenos Aires, Argentina; †Sanatorio Trinidad Mitre, Ciudad Autónoma de Buenos Aires;

Main Article

Table

Antibiotic susceptibility, isolectric focusing of β-lactamases and PCR of antimicrobial resistance determinants in Klebsiella pneumoniae, Citrobacter freundii clinical isolates, Salmonella transconjugants, and recipient and control strains*

Type of testing Clinical isolates
 Transconjugants and recipient strains
 Control strains
K.p. M9171 C.f. M9169 Salmonella
M9204† Salmonella
M9190‡ Salmonella M1744 K.p. D5/07§ K.p. C2¶ E. coli ATCC 25922
MICs (µg/mL)
Antimicrobial agent
Imipenem 32 1.0 1.0 1.0 0.12 2.0 0.12 0.25
Impenem/clavulanate 32 0.25 0.25 0.25 0.12 0.5 0.12 0.25
Impenem/APB 2.0 0.12 0.25 0.12 0.12 0.12 0.12 0.25
Imipenem/EDTA# 32 0.25 1.0 1.0 0.12 2.0 0.12 0.12
Meropenem 32 1.0 0.5 1.0 0.015 2.0 0.03 0.03
Meropenem/clavulanate 32 0.12 0.03 0.06 0.015 1.0 0.03 0.03
Meropenem/APB 1.0 0.06 0.03 0.03 0.015 0.12 0.03 0.03
Meropenem/EDTA# 32 1.0 0.5 1.0 0.015 2.0 0.03 0.03
Ertapenem 128 2.0 1.0 1.0 0.008 16 0.06 0.015
Ertapenem/clavulanate 128 0.25 0.03 0.06 0.008 16 0.06 0.008
Ertapenem/APB 8.0 0.008 0.015 0.03 0.008 0.5 0.03 0.008
Cefoxitin 64 64 4.0 8.0 2.0 ND ND 4
Ceftazidime 256 16 16 32 0.06 ND ND 0.25
Ceftazidime/clavulante 16 32 0.5 0.5 0.06 ND ND ND
Cefepime 32 4.0 16 16 0.03 ND ND 0.03
Cefepime/clavulanate 16 0.25 0.5 0.25 0.03 ND ND ND
Tigecycline**
 1.0
 0.25
ND
 ND
 ND
ND
 ND
 0.25
Isolectric focusing results
pI band††
 5.4 + 6.7 + 7.6
 5.4 + 6.7 + >9.0
6.7
 6.7
 None
ND
 ND
 None
PCR results
Β-lactamase
blaKPC + + + + – + – ND
blaampC – + 
CIT/
CMY – – – – +
CIT/
CMY ND
blaPER-2 + – – – – ND ND ND
blaSHV + – – – – ND ND ND
blaTEM-1 + + – – – ND ND ND

*K.p., Klebsiella pneumoniae; C.f., Citrobacter freundii; E. coli, Escherichia coli; APB, 3-aminophenylboronic acid; IEF, isoelectric focusing; pI, isoelectric point; ND, not determined; +, positive; –, negative.
†M9204 transconjugant derived from K. pneumoniae M9171.
‡M9190 transconjugant derived from C. freundii M9169.
§Control strain producing KPC-2.
¶Control strain producing CMY-2.
#EDTA 0.4 mmol/L.
**Microdilution (JustOne, Trek Diagnostic Systems, Cleveland, OH, USA). Breakpoints according to US Food and Drug Administration (susceptible <2 μg/mL).
††Underlined pI bands indicated activity against third-generation cephalosporins

Main Article

Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external